Probiotic treatment with Probioflora in patients with predicted severe acute pancreatitis without organ failure

Pancreatology

Volumn 12, Issue 5, 2012, Pages 458-462

  Van Baal, M C ^a   Kohout, P ^b   Besselink, M G ^c,d   Van Santvoort, H C ^c   Benes, Z ^b   Zazula, R ^e   Rijkers, G T ^a   Gooszen, H G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e Faculty Thomayer's Hospital   (Czech Republic)

Author keywords

Acute pancreatitis; Non occlusive mesenteric ischemia; Nutrition; Probiotics

Indexed keywords

PROBIOFLORA; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; AGED; BACTEREMIA; CONFERENCE PAPER; ENTERIC FEEDING; FEMALE; HUMAN; INTESTINE ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NECROSIS; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TOTAL PARENTERAL NUTRITION;

EID: 84873086399     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2012.08.004     Document Type: Conference Paper

References (22)

1. UK guidelines for the management of acute pancreatitis. Gut 2005; 54(Suppl. 3): iii1-9.
2. Besselink MG, van Santvoort HC, Boermeester MA, Nieuwenhuijs VB, van Goor H, Dejong CH, et al Timing and impact of infections in acute pancreatitis. Br J Surg 2009; 96(3): 267-73.
3. Ammori BJ, Leeder PC, King R.F., Barclay GR, Martin IG, Larvin M, et al Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg 1999; 3(3): 252-62.
4. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990; 125(3): 403-4. (Pubitemid 20079089)
5. Van Leeuwen P.A., Boermeester MA, Houdijk A.P., Ferwerda CC, Cuesta MA, Meyer S, et al Clinical significance of translocation. Gut 1994; 35(Suppl. 1): S28-34. (Pubitemid 24059503)
6. Besselink MG, van Santvoort HC, Renooij W, de Smet MB, Boermeester MA, Fischer K, et al Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg 2009 Nov; 250(5): 712-9.
7. de Vries A.C., Besselink MG, Buskens E, Ridwan B.U., Schipper M., van Erpecum KJ, et al Randomized controlled trials of antibiotic prophylaxis in severe acute pancreatitis: relationship between methodological quality and outcome. Pancreatology 2007; 7(5-6): 531-8. (Pubitemid 47587633)
8. Wittau M, Mayer B, Scheele J., Henne-Bruns D, Dellinger EP, Isenmann R. Systematic review and meta-analysis of antibiotic prophylaxis in severe acute pancreatitis. Scand J Gastroenterol 2011; 46(3): 261-70.
9. Petrov MS, van Santvoort HC, Besselink MG, van der Heijden GJ, Windsor JA, Gooszen HG. Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials. Arch Surg 2008 Nov; 143(11): 1111-7.
10. Al-Omran M., Albalawi ZH, Tashkandi M.F., Al-Ansary LA. Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev 2010 Jan; 20(1).
11. Gatt M, MacFie J. Randomized clinical trial of gut-specific nutrients in critically ill surgical patients. Br J Surg 2010 Nov; 97(11): 1629-36.
12. Olah A, Belagyi T, Issekutz A., Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89(9): 1103-7. (Pubitemid 34989215)
13. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371(9613): 651-9.
14. Sharma B, Srivastava S, Singh N., Sachdev V, Kapur S, Saraya A., et al Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial. J Clin Gastroenterol 2011; 45(5): 442-8.
15. Lata J, Stiburek O. Prophylactic antibiotics and probiotics in acute pancreatitis. Vnitr Lek 2010; 56(6): 582-4.
16. Sand J, Nordback I. Probiotics in severe acute pancreatitis. Lancet 2008; 371(9613): 634-5. (Pubitemid 351273386)
17. Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC Prognostic factors in acute pancreatitis. Gut 1984; 25(12): 1340-6. (Pubitemid 15180519)
18. Werner J, Hartwig W, Uhl W., Müller C, Büchler MW. Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 2003; 3(2): 115-27. (Pubitemid 36577072)
19. Bradley III EL. A clinically based classification system for acute pancreatitis. Summary of the international symposium on acute pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128(5): 586-90. (Pubitemid 23143226)
20. Hirota M, Inoue K, Kimura Y., Mizumoto T, Kuwata K, Ohmuraya M., et al Non-occlusive mesenteric ischemia and its associated intestinal gangrene in acute pancreatitis. Pancreatology 2003; 3: 316-22. (Pubitemid 36928756)
21. Rychter JW, van Minnen LP, Verheem A, Timmerman HM, Rijkers G.T., Schipper ME, et al Pretreatment but not treatment with probiotics abolishes mouse intestinal barrier dysfunction in acute pancreatitis. Surgery 2009; 145(2): 157-67.
22. Isenmann R, Runzi M, Kron M., Kahl S, Kraus D, Jung N., et al Prophylactic antibiotic treatment in patients woth predicted severe acute pancreatitis; a placebo-controlled, double-blind trial. Gastroenterology 2004; 126: 997-1004. (Pubitemid 38451171)